The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
Open accessAbstract
OBJECTIVE: To compare the positive and negative effects of tacrolimus and ciclosporin as initial treatment for renal transplant recipients. DESIGN: Systematic review. DATA SOURCES AND STUDY SELECTION: Reports of comparative randomised trials of tacrolimus and ciclosporin identified by searches of Medline, Embase, the Cochrane Register of Controlled Trials, the Cochrane Renal Group Specialist Register, and conference proceedings. DATA EXTRACTION AND SYNTHESIS: Two reviewers assessed trials for eligibility and quality and extracted data independently. Data were synthesised (random effects model) and results expressed as relative risk (RR), with values < 1 favouring tacrolimus. Subgroup analysis and meta-regression were used to examine potential effect modification by differences in trial design and immunosuppressive co-interventions. RESULTS: 123 reports from 30 trials (4102 patients) were included. At six months, graft loss was significantly reduced in tacrolimus treated recipients (RR = 0.56, 95% confidence interval 0.36 to 0.86), and this effect persisted up to three years. The relative reduction in graft loss with tacrolimus diminished with higher concentrations of tacrolimus (P = 0.04) but did not vary with ciclosporin formulation (P = 0.97) or ciclosporin concentration (P = 0.38). At one year, tacrolimus treated patients had less acute rejection (RR = 0.69, 0.60 to 0.79) and less steroid resistant rejection (RR = 0.49, 0.37 to 0.64) but more diabetes mellitus requiring insulin (RR = 1.86, 1.11 to 3.09), tremor, headache, diarrhoea, dyspepsia, and vomiting. The relative excess of diabetes increased with higher concentrations of tacrolimus (P = 0.003). Ciclosporin treated recipients had significantly more constipation and cosmetic side effects. No differences were seen in infection or malignancy. CONCLUSIONS: Treating 100 recipients with tacrolimus instead of ciclosporin for the first year after transplantation avoids 12 patients having acute rejection and two losing their graft but causes an extra five patients to develop insulin dependent diabetes. Optimal drug choice may vary between patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The National Institute for Clinical Excellence
(2001) · Nursing Management · doi:10.7748/nm.8.2.39.s15 · Cited by 3,876
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
The Natural History of Chronic Allograft Nephropathy
Nankivell, B. J., Borrows, R. J., Fung, C. L.-S., O'Connell, P. J., Allen, R. D. M., & Chapman, J. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020009 · Cited by 1,949
Self-citationTunis (2003) · doi:10.1001/jama.290.12.1624 · Cited by 1,724
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Meier-Kriesche, H.-U., Schold, J. D., Srinivas, T. R., & Kaplan, B. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00332.x · Cited by 1,287
Pirsch, J. D., Miller, J., Deierhoi, M. H., Vincenti, F., & Filo, R. S. (1997) · Transplantation · doi:10.1097/00007890-199704150-00013 · Cited by 1,122
Strategies to Improve Long-Term Outcomes after Renal Transplantation
Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N., & Cosimi, A. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011295 · Cited by 844
Mayer, A. D., Dmitrewski, J., Squifflet, J.-P., Besse, T., Grabensee, B., Klein, B., Eigler, F. W., Heemann, U., Pichlmayr, R., Behrend, M., et al. (1997) · Transplantation · doi:10.1097/00007890-199708150-00012 · Cited by 724
Cardiovascular disease after renal transplantation.
Kasiske, B. L., Guijarro, C., Massy, Z. A., Wiederkehr, M. R., & Ma, J. Z. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v71158 · Cited by 669
Heisel, O., Heisel, R., Balshaw, R., & Keown, P. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00372.x · Cited by 506
Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology
Nankivell, B. J., Borrows, R. J., Fung, C. L.-S., O'Connell, P. J., Chapman, J. R., & Allen, R. D. M. (2004) · Transplantation · doi:10.1097/01.tp.0000128636.70499.6e · Cited by 498
Self-citationBerlin, J. A., Santanna, J., Schmid, C. H., Szczech, L. A., & Feldman, H. I. (2002) · Statistics in Medicine · doi:10.1002/sim.1023 · Cited by 468
Margreiter, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07875-3 · Cited by 450
Immunosuppressive strategies in transplantation
Denton, M. D., Magee, C. C., & Sayegh, M. H. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07493-5 · Cited by 449
Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future
de Mattos, A. M., Olyaei, A. J., & Bennett, W. M. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70348-9 · Cited by 429
Johnson, C., Ahsan, N., Gonwa, T., Halloran, P., Stegall, M., Hardy, M., Metzger, R., Shield, C., Rocher, L., Scandling, J., et al. (2000) · Transplantation · doi:10.1097/00007890-200003150-00028 · Cited by 294
Knoll, G. A., & Bell, R. C. (1999) · BMJ · doi:10.1136/bmj.318.7191.1104 · Cited by 263
Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation
Trompeter, R., Filler, G., Webb, N. J. A., Watson, A. R., Milford, D. V., Tyden, G., Grenda, R., Janda, J., Hughes, D., Ehrich, J. H. H., et al. (2002) · Pediatric Nephrology · doi:10.1007/s00467-001-0795-9 · Cited by 227
Problems and Limitations in Conducting Systematic Reviews
Egger, M., Dickersin, K., & Smith, G. D. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch3 · Cited by 202
Activity Level and Balance in Subjects with Mild Alzheimer’s Disease
Pettersson, A. F., Engardt, M., & Wahlund, L. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000057699 · Cited by 163
Immunosuppressive agents in organ transplantation: past, present, and future.
Hong, J. C., & Kahan, B. D. (2000) · PubMed · Cited by 145
Ichimaru, N., Takahara, S., Kokado, Y., Wang, J. D., Hatori, M., Kameoka, H., Inoue, T., & Okuyama, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00438-5 · Cited by 130
van Duijnhoven, E. M., Christiaans, M. H. L., Boots, J. M. M., Nieman, F. H. M., Wolffenbuttel, B. H. R., & van Hooff, J. P. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131213 · Cited by 129
Pediatric renal transplantation: a review of the UNOS data. United Network for Organ Sharing.
Cecka, J. M., Gjertson, D. W., & Terasaki, P. I. (1997) · PubMed · Cited by 114
Cardiovascular disease after renal transplantation.
Kasiske, B. L. (2000) · PubMed · Cited by 114
Balancing benefits and harms in health care
Cuervo, L. G., & Clarke, M. J. (2003) · BMJ · doi:10.1136/bmj.327.7406.65 · Cited by 105
Radermacher, J., Meiners, M., Bramlage, C., Kliem, V., Behrend, M., Schlitt, H. J., Pichlmayr, R., Koch, K. M., & Brunkhorst, R. R. (1998) · Transplant International · doi:10.1111/j.1432-2277.1998.tb00948.x · Cited by 101
Late deterioration of organ transplants: a problem in injury and homeostasis
Gourishankar, S., & Halloran, P. F. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00386-2 · Cited by 78
Lachenbruch, P. A., Rosenberg, A. S., Bonvini, E., Cavaillé-Coll, M. W., & Colvin, R. B. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00386.x · Cited by 73
Inferior outcome of two-haplotype matched renal transplants in blacks: Role of early rejection
OJO, A. O., Port, F. K., Held, P. J., Wolfe, R. A., Turenne, M. N., Chung, E., Mauger, E. A., & Leichtman, A. B. (1995) · Kidney International · doi:10.1038/ki.1995.452 · Cited by 57
Morris-Stiff, G., Ostrowski, K., Balaji, V., Moore, R. H., DARBY, C. R., Lord, R. H. H., & Jurewicz, W. A. (1998) · Transplant International · doi:10.1007/s001470050492 · Cited by 25
Campos, H. H., & Filho, M. A. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)02968-8 · Cited by 16
Charpentier, B. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)03048-8 · Cited by 16
Haggan, W. E., Barthe, N., Vendrely, B., Chauveau, P., Berger, F., Aparicio, M., & Potaux, L. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)03094-4 · Cited by 15
Cited by
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Ekberg, H., Tedesco-Silva, H., Demirbas, A., Vítko, Š., Nashan, B., Gürkan, A., Margreiter, R., Hugo, C., Grinyó, J. M., Frei, U., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067411 · Cited by 1,810
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Calcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Uncertainty in heterogeneity estimates in meta-analyses
Ioannidis, J. P. A., Patsopoulos, N. A., & Evangelou, E. (2007) · BMJ · doi:10.1136/bmj.39343.408449.80 · Cited by 1,254
Vincenti, F., Friman, S., Scheuermann, E., Rostaing, L., Jenssen, T., Campistol, J. M., Uchida, K., Pescovitz, M. D., Marchetti, P., Tuncer, M., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01749.x · Cited by 619
Metadata
- Authors
- Webster, A. C., Woodroffe, R. C., Taylor, R. S., Chapman, J. R., & Craig, J. C.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2005-09-12
- Volume
- 331
- Issue
- 7520
- Pages
- 810
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2117184184
- Cited by
- 587
- References
- 38
- FWCI
- 15.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.